Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan P van Meerbeeck

Showing results (1-10 of 190) with videos related to

Pageof 19
Sort By:
The Lancet. Oncology|July 5, 2008
The controversial role of surgery in stage III NSCLCJan P van Meerbeeck
Translational Lung Cancer Research|March 26, 2015
Radiotherapy for single station N2 NSCLCJan P van Meerbeeck
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Novel teatment options in early-stage non-small-cell lung cancerJan P van Meerbeeck
Translational Lung Cancer Research|September 18, 2015
Rebuttal from Dr van MeerbeeckJan P van Meerbeeck
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Chemotherapy in malignant mesothelioma: what's up, doc?Jan P van Meerbeeck
Respirology (Carlton, Vic.)|July 14, 2011
Facts, rumours and speculations about the mesothelioma epidemicJan P van Meerbeeck, Ronald Damhuis
Translational Lung Cancer Research|September 18, 2015
Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancerJan P van Meerbeeck, Halil Sirimsi
European Journal of Cancer (Oxford, England : 1990)|June 16, 2009
Palliative chemotherapy: do we need yet another end-point?Jan P van Meerbeeck, Paul Baas
Translational Lung Cancer Research|June 24, 2021
Lung cancer screening in Europe: where are we in 2021?Jan P van Meerbeeck, Caro Franck
Expert Opinion on Pharmacotherapy|April 26, 2006
Pemetrexed in thoracic cancerHannelore Goeminne, Jan P van Meerbeeck
Pageof 19

Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
The Lancet. Oncology|July 5, 2008
The controversial role of surgery in stage III NSCLCJan P van Meerbeeck
Translational Lung Cancer Research|March 26, 2015
Radiotherapy for single station N2 NSCLCJan P van Meerbeeck
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Novel teatment options in early-stage non-small-cell lung cancerJan P van Meerbeeck
Translational Lung Cancer Research|September 18, 2015
Rebuttal from Dr van MeerbeeckJan P van Meerbeeck
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Chemotherapy in malignant mesothelioma: what's up, doc?Jan P van Meerbeeck
Respirology (Carlton, Vic.)|July 14, 2011
Facts, rumours and speculations about the mesothelioma epidemicJan P van Meerbeeck, Ronald Damhuis
Translational Lung Cancer Research|September 18, 2015
Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancerJan P van Meerbeeck, Halil Sirimsi
European Journal of Cancer (Oxford, England : 1990)|June 16, 2009
Palliative chemotherapy: do we need yet another end-point?Jan P van Meerbeeck, Paul Baas
Translational Lung Cancer Research|June 24, 2021
Lung cancer screening in Europe: where are we in 2021?Jan P van Meerbeeck, Caro Franck
Expert Opinion on Pharmacotherapy|April 26, 2006
Pemetrexed in thoracic cancerHannelore Goeminne, Jan P van Meerbeeck
Pageof 19